Keros Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -101319%. Total operating expenses were $170,092,000.
Profit Margin
| 2018 | 10M | -1.33M | -13.35% |
|---|---|---|---|
| 2019 | 10M | -12.34M | -123.44% |
| 2020 | 0 | -45.36M | |
| 2021 | 20.1M | -58.74M | -292.26% |
| 2022 | 0 | -104.68M | |
| 2023 | 151K | -152.99M | -101319.21% |
KROS Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 151K | 0 | 20.1M | 0 | 10M | 10M |
Cost of revenue | 815K | 1.61M | 898K | 605K | 17.34M | 0 |
Gross profit | -664K | -1.61M | 19.20M | -605K | -7.34M | 10M |
Operating exp. | ||||||
Research and development | 135.25M | 87.26M | 55.14M | 33.86M | 17.37M | 10.11M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 170.09M | 107.70M | 76.47M | 44.19M | 20.00M | 11.32M |
Operating income | -169.94M | -114.79M | -56.37M | -46.65M | -10.56M | -1.69M |
Other income (expenses), net | 16.94M | 10.11M | -360K | 1.12M | -1.77M | 237K |
Income before tax | -152.99M | -104.67M | -56.73M | -45.53M | -12.33M | -1.07M |
Income tax expense | 0 | 1K | 2.01M | -172K | 8K | 257K |
Net income | -152.99M | -104.68M | -58.74M | -45.36M | -12.34M | -1.33M |
Earnings per share | ||||||
Basic EPS | -5.2 | -4.15 | -2.52 | -2.93 | -1.39 | -0.15 |
Diluted EPS | -5.2 | -4.15 | -2.52 | -2.93 | -1.39 | -0.15 |
| Data source | Data source | Data source |